Overall Survival with Durvalumab versus Placebo after simultaneous Stage III Chemoradiotherapy NSCLC: Updated Data from the PACIFIC Study

De Wit, M. and Schulz, C. and Laak, E. and Wolff, T. and Rueckert, A. and Faehling, M. and Fischer, J. R. and Reck, M. (2019) Overall Survival with Durvalumab versus Placebo after simultaneous Stage III Chemoradiotherapy NSCLC: Updated Data from the PACIFIC Study. STRAHLENTHERAPIE UND ONKOLOGIE, 195 (1Suppl). S50. ISSN 0179-7158, 1439-099X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Petra Gürster
Date Deposited: 31 Mar 2020 06:42
Last Modified: 31 Mar 2020 06:42
URI: https://pred.uni-regensburg.de/id/eprint/26943

Actions (login required)

View Item View Item